An editorial in the influential New England Journal of Medicine cites problems with a World Health Organization (WHO) study that found Gilead Sciences Inc's antiviral remdesivir failed to improve ...
The frontrunners in the COVID-19 vaccine race have emerged with different success rates for their shots in clinical trials, but what does that mean for the global fight against the pandemic?
Researchers, funders, and industry experts in 2D materials call for science to reward reliability over speed, proposing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback